Compromised Blood-Brain Barrier Junctions Enhance Melanoma Cell Intercalation and Extravasation

Author:

Saltarin Federico1,Wegmüller Adrian1ORCID,Bejarano Leire23,Ildiz Ece Su1,Zwicky Pascale1ORCID,Vianin Andréj45,Spadin Florentin6,Soukup Klara23ORCID,Wischnewski Vladimir23,Engelhardt Britta1,Deutsch Urban1,J. Marques Ines45,Frenz Martin6ORCID,Joyce Johanna A.23,Lyck Ruth1ORCID

Affiliation:

1. Theodor Kocher Institute, University of Bern, 3012 Bern, Switzerland

2. Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland

3. Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland

4. Department of Developmental Biology and Regeneration, Institute of Anatomy, University of Bern, 3012 Bern, Switzerland

5. Department for BioMedical Research (DBMR), University of Bern, 3010 Bern, Switzerland

6. Institute of Applied Physics, University of Bern, 3012 Bern, Switzerland

Abstract

Melanoma frequently metastasises to the brain, and a detailed understanding of the molecular and cellular mechanisms underlying melanoma cell extravasation across the blood-brain barrier (BBB) is important for preventing brain metastasis formation. Making use of primary mouse brain microvascular endothelial cells (pMBMECs) as an in vitro BBB model, we imaged the interaction of melanoma cells into pMBMEC monolayers. We observed exclusive junctional intercalation of melanoma cells and confirmed that melanoma-induced pMBMEC barrier disruption can be rescued by protease inhibition. Interleukin (IL)-1β stimulated pMBMECs or PECAM-1-knockout (-ko) pMBMECs were employed to model compromised BBB barrier properties in vitro and to determine increased melanoma cell intercalation compared to pMBMECs with intact junctions. The newly generated brain-homing melanoma cell line YUMM1.1-BrM4 was used to reveal increased in vivo extravasation of melanoma cells across the BBB of barrier-compromised PECAM-1-deficient mice compared to controls. Taken together, our data indicate that preserving BBB integrity is an important measure to limit the formation of melanoma-brain metastasis.

Funder

Foundation for Clinical-Experimental Cancer Research

Berne University Research Foundation

Ludwig Foundation for Cancer Research and the University of Lausanne

Swiss National Science Foundation

Human Frontier Science Program and the European Molecular Biology Organisation

Ruth & Arthur Scherbarth Stiftung

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3